IAIM
CBAY

International Assets Investment Management’s Cymabay Therapeutics CBAY Stock Holding History

International Assets Investment Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,237
Closed -$30K – 2031
2021
Q1 		$30K Hold
5,237
– – ﹤0.01% 1143
2020
Q4 		$30K Buy
+5,237
New +$39.6K 0.01% 1024

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

International Assets Investment Management's CBAY Position: Q2 2021 in Review

International Assets Investment Management sold out of Cymabay Therapeutics (CBAY) in Q2 2021, closing a stake of 5,237 shares — an estimated $30K sold.

International Assets Investment Management first reported a position in CBAY in Q4 2020 and held it in 2 quarters. The position peaked at $30K in Q1 2021. 113 funds tracked by Wall St. Rank hold CBAY as of Q2 2021.

  • International Assets Investment Management reported no remaining Cymabay Therapeutics position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 5,237 Cymabay Therapeutics shares in Q2 2021, an estimated $30K.
  • International Assets Investment Management first reported a position in Cymabay Therapeutics in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Cymabay Therapeutics position peaked at $30K in Q1 2021.
  • 113 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.